Status:
UNKNOWN
Detection of CTC and ctDNA in the Diagnosis of Metastasis in Gastric Cancer
Lead Sponsor:
First Hospital of China Medical University
Conditions:
Stomach Neoplasms
Metastasis
Eligibility:
All Genders
18-79 years
Brief Summary
To investigate the value of CTCs and ctDNA in the diagnosis of metastasis in ascites/peritoneal flushing fluid and blood; To investigate the influence of laparoscopic CO2 pneumoperitoneum establishmen...
Eligibility Criteria
Inclusion
- Patients who sign informed consent.
- Gastric cancer is determined by more than 2 pathologists.
- Patients with Borrmann III/IV gastric cancer.
Exclusion
- Patients who complicate with other malignant tumors.
- Patients who complicate with other serious heart and lung diseases.
- Patients who receive preoperative neoadjuvant chemotherapy.
Key Trial Info
Start Date :
January 1 2022
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
January 31 2024
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT05208372
Start Date
January 1 2022
End Date
January 31 2024
Last Update
January 26 2022
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
First Hospital of Jinzhou Medical University
Jinzhou, Liaoning, China, 121012
2
The First Affiliated Hospital of China Medical University
Shenyang, Liaoning, China, 110000